<?xml version="1.0" encoding="UTF-8"?>
<ref id="B70-biomedicines-08-00060">
 <label>70.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Nakashima</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Decklever</surname>
    <given-names>T.D.</given-names>
   </name>
   <name>
    <surname>Nace</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Russell</surname>
    <given-names>S.J.</given-names>
   </name>
  </person-group>
  <article-title>HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy</article-title>
  <source>Cancer Gene Ther.</source>
  <year>2013</year>
  <volume>20</volume>
  <fpage>478</fpage>
  <lpage>485</lpage>
  <pub-id pub-id-type="doi">10.1038/cgt.2013.43</pub-id>
  <pub-id pub-id-type="pmid">23868101</pub-id>
 </element-citation>
</ref>
